Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
US8653022B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Inventor
Key dates
| Filing date | Mar 27, 2007 |
| Grant date | Feb 18, 2014 |
| Priority date | — |
| Expiry date | Jul 28, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and/or prevention of hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or CHD and/or weight management and/or diabetes and/or hyperglycemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.